Response by Di Tullio et al. to Letter Regarding Article “Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus A...

par Di Tullio, Marco R., Thompson, John L.P., Homma, Shunichi
Publié dans Stroke (2016)

Diagnostic odyssey of patients with mitochondrial disease: Results of a survey

par Grier, Johnston, Hirano, Michio, Karaa, Amel, Shepard, Emma, Thompson, John L.P.
Publié dans Neurol Genet (2018)

Web-based data management for a phase II clinical trial in ALS

par Buchsbaum, Richard, Kaufmann, Petra, Barsdorf, Alexandra I., Arbing, Rachel, Montes, Jacqueline, Thompson, John L.P.
Publié dans Amyotroph Lateral Scler (2009)

Mitochondrial Disease Patients’ Perception of Dietary Supplements’ Use

par Karaa, Amel, Kriger, Joshua, Grier, Johnston, Holbert, Amy, Thompson, John L.P, Parikh, Sumit, Hirano, Michio
Publié dans Mol Genet Metab (2016)

Development of a Novel Observer Reported Outcome Tool as the Primary Efficacy Outcome Measure for a Rare Disease Randomized Controlled Trial

par Stacpoole, Peter W., Shuster, Jonathan, Thompson, John L. P. (Seamus), Nixon, Sara Jo, Prather, Robert A., Lawson, Lee Ann, Zou, Baiming, Buchsbaum, Richard
Publié dans Mitochondrion (2017)

Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial

par Matsumoto, Kenji, Xiao, Yi, Homma, Shunichi, Thompson, John L.P., Buchsbaum, Richard, Ito, Kazato, Anker, Stefan D., Qian, Min, Di Tullio, Marco R.
Publié dans ESC Heart Fail (2020)

Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy

par Engelstad, Kristin, Sklerov, Miriam, Kriger, Joshua, Sanford, Alexandra, Grier, Johnston, Ash, Daniel, Egli, Dieter, DiMauro, Salvatore, Thompson, John L.P., Sauer, Mark V., Hirano, Michio
Publié dans Hum Reprod (2016)

The North American mitochondrial disease registry

par Rosales, Xiomara Q., Thompson, John L. P., Haas, Richard, Van Hove, Johan L. K., Karaa, Amel, Krotoski, Danuta, Engelstad, Kristin, Buchsbaum, Richard, DiMauro, Salvatore, Hirano, Michio
Publié dans J Transl Genet Genom (2020)

Mitochondrial disease patient motivations and barriers to participate in clinical trials

par Zolkipli-Cunningham, Zarazuela, Xiao, Rui, Stoddart, Amy, McCormick, Elizabeth M., Holberts, Amy, Burrill, Natalie, McCormack, Shana, Williams, Lauren, Wang, Xiaoyan, Thompson, John L. P., Falk, Marni J.
Publié dans PLoS One (2018)

Amino terminal pro–B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy

par Longstreth, WT, Kronmal, Richard A, Thompson, John L P, Christenson, Robert H, Levine, Steven R, Gross, Rebecca, Brey, Robin L, Buchsbaum, Richard, Elkind, Mitchell SV, Tirschwell, David L, Seliger, Stephen L, Mohr, JP, deFilippi, Christopher R
Publié 2013

Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke: Results of a Prematurely Terminated Randomized Clinical Trial

par Haley, E. Clarke, Thompson, John L.P., Grotta, James C., Lyden, Patrick D., Hemmen, Thomas G., Brown, Devin L., Fanale, Christopher, Libman, Richard, Kwiatkowski, Thomas G., Llinas, Rafael H., Levine, Steven R., Johnston, Karen C., Buchsbaum, Richard, Levy, Gilberto, Levin, Bruce
Publié 2010

Designing Clinical Trials for Dystonia

par Galpern, Wendy R., Coffey, Christopher S., Albanese, Alberto, Cheung, Ken, Comella, Cynthia L., Ecklund, Dixie J., Fahn, Stanley, Jankovic, Joseph, Kieburtz, Karl, Lang, Anthony E., McDermott, Michael P., Shefner, Jeremy M., Teller, Jan K., Thompson, John L. P., Yeatts, Sharon D., Jinnah, H. A.
Publié 2013

RECURRENT STROKE IN THE WARFARIN VERSUS ASPIRIN IN REDUCED EJECTION FRACTION (WARCEF) TRIAL

par Pullicino, Patrick M., Qian, Min, Sacco, Ralph L., Freudenberger, Ron, Graham, Susan, Teerlink, John R., Mann, Douglas, Di Tullio, Marco R., Ponikowski, Piotr, Lok, Dirk J., Anker, Stefan D., Lip, Gregory Y.H., Estol, Conrado J., Levin, Bruce, Mohr, J.P., Thompson, John L. P., Homma, Shunichi
Publié dans Cerebrovasc Dis (2014)

Stroke in Heart Failure in Sinus Rhythm: The Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial

par Pullicino, Patrick M., Thompson, John L.P., Sacco, Ralph L., Sanford, Alexandra R., Qian, Min, Teerlink, John R., Haddad, Haissam, Diek, Monika, Freudenberger, Ronald S., Labovitz, Arthur J., Di Tullio, Marco R., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Graham, Susan, Mann, Douglas L., Mohr, J.P., Homma, Shunichi
Publié dans Cerebrovasc Dis (2013)

Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients—from the WARCEF Trial

par Teerlink, John R., Qian, Min, Bello, Natalie A., Freudenberger, Ronald S., Levin, Bruce, Di Tullio, Marco R., Graham, Susan, Mann, Douglas L., Sacco, Ralph L., Mohr, J.P., Lip, Gregory Y.H., Labovitz, Arthur J., Lee, Seitetz C., Ponikowski, Piotr, Lok, Dirk J., Anker, Stefan D., Thompson, John L.P., Homma, Shunichi
Publié dans JACC Heart Fail (2017)

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data from the WARCEF trial

par Di Tullio, Marco R., Qian, Min, Thompson, John L.P., Labovitz, Arthur J., Mann, Douglas L., Sacco, Ralph L., Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Graham, Susan, Lip, Gregory Y. H., Levin, Bruce, Mohr, J P, Buchsbaum, Richard, Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Homma, Shunichi
Publié dans Stroke (2016)

Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment

par Di Tullio, Marco R., Qian, Min, Thompson, John L.P., Labovitz, Arthur J., Mann, Douglas L., Sacco, Ralph L., Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Graham, Susan, Lip, Gregory Y.H., Levin, Bruce, Mohr, Jay P., Buchsbaum, Richard, Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Homma, Shunichi
Publié dans ESC Heart Fail (2018)

Quality of Anticoagulation Control in Preventing Adverse Events in Heart Failure Patients in Sinus Rhythm: A Warfarin Aspirin Reduced Cardiac Ejection Fraction Trial (WARCEF) Subst...

par Homma, Shunichi, Thompson, John L.P., Qian, Min, Ye, Siqin, Di Tullio, Marco R., Lip, Gregory Y.H., Mann, Douglas L., Sacco, Ralph L., Levin, Bruce, Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Graham, Susan, Mohr, J.P., Labovitz, Arthur J., Buchsbaum, Richard, Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D.
Publié dans Circ Heart Fail (2015)

Resting heart rate and ischemic stroke in patients with heart failure

par Nakanishi, Koki, Di Tullio, Marco R., Qian, Min, Thompson, John L.P., Labovitz, Arthur J., Mann, Douglas L., Sacco, Ralph L., Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Graham, Susan, Lip, Gregory Y. H., Levin, Bruce, Mohr, J P, Buchsbaum, Richard, Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Homma, Shunichi
Publié dans Cerebrovasc Dis (2017)

Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

par Graham, Susan, Ye, Siqin, Qian, Min, Sanford, Alexandra R., Di Tullio, Marco R., Sacco, Ralph L., Mann, Douglas L., Levin, Bruce, Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Mohr, J. P., Labovitz, Arthur J., Lip, Gregory Y. H., Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Thompson, John L. P., Homma, Shunichi
Publié dans PLoS One (2014)